Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, double-blind, placebo-controlled multicenter study evaluating
the efficacy and safety of two doses of favipiravir in adult patients with uncomplicated
influenza.